{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:21:24Z","timestamp":1794018084679,"version":"4.8.0"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T00:00:00Z","timestamp":1547424000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1038\/s41575-018-0099-1","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T06:36:26Z","timestamp":1547447786000},"page":"235-246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":664,"title":["Alcohol, liver disease and the gut microbiota"],"prefix":"10.1038","volume":"16","author":[{"given":"Jasmohan S.","family":"Bajaj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jhep.2013.03.007","volume":"59","author":"J Rehm","year":"2013","unstructured":"Rehm, J., Samokhvalov, A. V. & Shield, K. D. Global burden of alcoholic liver diseases. J. Hepatol. 59, 160\u2013168 (2013).","journal-title":"J. Hepatol."},{"key":"99_CR2","unstructured":"World Health Organization. Global status on alcohol and health 2014. WHO \n                    http:\/\/www.who.int\/substance_abuse\/publications\/global_alcohol_report\/msb_gsr_2014_1.pdf\n                    \n                   (2014)."},{"key":"99_CR3","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2015.03.006","volume":"62","author":"P Mathurin","year":"2015","unstructured":"Mathurin, P. & Bataller, R. Trends in the management and burden of alcoholic liver disease. J. Hepatol. 62, S38\u2013S46 (2015).","journal-title":"J. Hepatol."},{"key":"99_CR4","unstructured":"Yoon, Y. & Chen, C. M. Surveillance report #105. NIAAA \n                    https:\/\/pubs.niaaa.nih.gov\/publications\/surveillance105\/Cirr13.pdf\n                    \n                   (2016)."},{"key":"99_CR5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11894-005-0063-4","volume":"7","author":"SJ Mills","year":"2005","unstructured":"Mills, S. J. & Harrison, S. A. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr. Gastroenterol. Rep. 7, 32\u201336 (2005).","journal-title":"Curr. Gastroenterol. Rep."},{"key":"99_CR6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ajg.2017.469","volume":"113","author":"AK Singal","year":"2018","unstructured":"Singal, A. K., Bataller, R., Ahn, J., Kamath, P. S. & Shah, V. H. ACG clinical guideline: alcoholic liver disease. Am. J. Gastroenterol. 113, 175\u2013194 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"99_CR7","unstructured":"National Institute on Alcohol Abuse and Alcoholism. Alcohol facts and statistics. NIAAA \n                    https:\/\/www.niaaa.nih.gov\/alcohol-health\/overview-alcohol-consumption\/alcohol-facts-and-statistics\n                    \n                   (2018)."},{"key":"99_CR8","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1002\/hep.22010","volume":"46","author":"S Zakhari","year":"2007","unstructured":"Zakhari, S. & Li, T. K. Determinants of alcohol use and abuse: impact of quantity and frequency patterns on liver disease. Hepatology 46, 2032\u20132039 (2007).","journal-title":"Hepatology"},{"key":"99_CR9","doi-asserted-by":"crossref","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","volume":"302","author":"EA Mutlu","year":"2012","unstructured":"Mutlu, E. A. et al. Colonic microbiome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G966\u2013G978 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"99_CR10","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","volume":"148","author":"G Szabo","year":"2015","unstructured":"Szabo, G. Gut-liver axis in alcoholic liver disease. Gastroenterology 148, 30\u201336 (2015).","journal-title":"Gastroenterology"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/15622970801896390","volume":"9","author":"M Soyka","year":"2008","unstructured":"Soyka, M. et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of substance use and related disorders, part 1: alcoholism. World J. Biol. Psychiatry 9, 6\u201323 (2008).","journal-title":"World J. Biol. Psychiatry"},{"key":"99_CR12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1360-0443.2006.01310.x","volume":"101","author":"RH Moos","year":"2006","unstructured":"Moos, R. H. & Moos, B. S. Rates and predictors of relapse after natural and treated remission from alcohol use disorders. Addiction 101, 212\u2013222 (2006).","journal-title":"Addiction"},{"key":"99_CR13","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1572-0241.2000.02026.x","volume":"95","author":"H Rosa","year":"2000","unstructured":"Rosa, H., Silverio, A. O., Perini, R. F. & Arruda, C. B. Bacterial infection in cirrhotic patients and its relationship with alcohol. Am. J. Gastroenterol. 95, 1290\u20131293 (2000).","journal-title":"Am. J. Gastroenterol."},{"key":"99_CR14","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1002\/lt.24163","volume":"21","author":"V Ahluwalia","year":"2015","unstructured":"Ahluwalia, V. et al. The etiology of cirrhosis is a strong determinant of brain reserve: a multimodal magnetic resonance imaging study. Liver Transpl. 21, 1123\u20131132 (2015).","journal-title":"Liver Transpl."},{"key":"99_CR15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.26972","volume":"59","author":"P Martin","year":"2014","unstructured":"Martin, P., DiMartini, A., Feng, S., Brown, R. Jr & Fallon, M. Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. Hepatology 59, 1144\u20131165 (2014).","journal-title":"Hepatology"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/hep.29338","volume":"66","author":"J Altamirano","year":"2017","unstructured":"Altamirano, J. et al. Alcohol abstinence in patients surviving an episode of alcoholic hepatitis: prediction and impact on long-term survival. Hepatology 66, 1842\u20131853 (2017).","journal-title":"Hepatology"},{"key":"99_CR17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project, C","year":"2012","unstructured":"Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","journal-title":"Nature"},{"key":"99_CR18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1136\/gutjnl-2015-310746","volume":"66","author":"H Sokol","year":"2016","unstructured":"Sokol, H. et al. Fungal microbiota dysbiosis in IBD. Gut 66, 1039\u20131048 (2016).","journal-title":"Gut"},{"key":"99_CR19","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/gutjnl-2016-313170","volume":"67","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. et al. Fungal dysbiosis in cirrhosis. Gut 67, 1146\u20131154 (2018).","journal-title":"Gut"},{"key":"99_CR20","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1172\/JCI90562","volume":"127","author":"AM Yang","year":"2017","unstructured":"Yang, A. M. et al. Intestinal fungi contribute to development of alcoholic liver disease. J. Clin. Invest. 127, 2829\u20132841 (2017).","journal-title":"J. Clin. Invest."},{"key":"99_CR21","doi-asserted-by":"crossref","first-page":"e01492","DOI":"10.1128\/mBio.01492-17","volume":"8","author":"KB Hooks","year":"2017","unstructured":"Hooks, K. B. & O\u2019Malley, M. A. Dysbiosis and its discontents. mBio 8, e01492\u201317 (2017).","journal-title":"mBio"},{"key":"99_CR22","first-page":"26050","volume":"26","author":"JM Rodriguez","year":"2015","unstructured":"Rodriguez, J. M. et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 26, 26050 (2015).","journal-title":"Microb. Ecol. Health Dis."},{"key":"99_CR23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","volume":"65","author":"D Vandeputte","year":"2016","unstructured":"Vandeputte, D. et al. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65, 57\u201362 (2016).","journal-title":"Gut"},{"key":"99_CR24","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nature25973","volume":"555","author":"D Rothschild","year":"2018","unstructured":"Rothschild, D. et al. Environment dominates over host genetics in shaping human gut microbiota. Nature 555, 210\u2013215 (2018).","journal-title":"Nature"},{"key":"99_CR25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu, G. D. et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 334, 105\u2013108 (2011).","journal-title":"Science"},{"key":"99_CR26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/hep.29791","volume":"68","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. et al. Diet affects gut microbiota and modulates hospitalization risk differentially in an international cirrhosis cohort. Hepatology 68, 234\u2013247 (2018).","journal-title":"Hepatology"},{"key":"99_CR27","first-page":"1","volume":"39","author":"V Iebba","year":"2016","unstructured":"Iebba, V. et al. Eubiosis and dysbiosis: the two sides of the microbiota. New Microbiol. 39, 1\u201312 (2016).","journal-title":"New Microbiol."},{"key":"99_CR28","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.cell.2016.11.018","volume":"167","author":"TR Sampson","year":"2016","unstructured":"Sampson, T. R. et al. Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson\u2019s disease. Cell 167, 1469\u20131480 (2016).","journal-title":"Cell"},{"key":"99_CR29","volume":"18","author":"HK Hughes","year":"2018","unstructured":"Hughes, H. K., Rose, D. & Ashwood, P. The gut microbiota and dysbiosis in autism spectrum disorders. Curr. Neurol. Neurosci. Rep. 18, 81 (2018).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"99_CR30","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni, J., Wu, G. D., Albenberg, L. & Tomov, V. T. Gut microbiota and IBD: causation or correlation? Nat. Rev. Gastroenterol. Hepatol. 14, 573\u2013584 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"99_CR31","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature14851","volume":"525","author":"JS Bajaj","year":"2015","unstructured":"Bajaj, J. S., Betrapally, N. S. & Gillevet, P. M. Decompensated cirrhosis and microbiome interpretation. Nature 525, E1\u2013E2 (2015).","journal-title":"Nature"},{"key":"99_CR32","doi-asserted-by":"crossref","first-page":"j831","DOI":"10.1136\/bmj.j831","volume":"356","author":"VB Young","year":"2017","unstructured":"Young, V. B. The role of the microbiome in human health and disease: an introduction for clinicians. BMJ 356, j831 (2017).","journal-title":"BMJ"},{"key":"99_CR33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D. J. & Hylemon, P. B. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes 7, 22\u201339 (2016).","journal-title":"Gut Microbes"},{"key":"99_CR34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cbdv.200900322","volume":"7","author":"P Gillevet","year":"2010","unstructured":"Gillevet, P., Sikaroodi, M., Keshavarzian, A. & Mutlu, E. A. Quantitative assessment of the human gut microbiome using multitag pyrosequencing. Chem. Biodivers. 7, 1065\u20131075 (2010).","journal-title":"Chem. Biodivers."},{"key":"99_CR35","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature11550","volume":"489","author":"CA Lozupone","year":"2012","unstructured":"Lozupone, C. A., Stombaugh, J. I., Gordon, J. I., Jansson, J. K. & Knight, R. Diversity, stability and resilience of the human gut microbiota. Nature 489, 220\u2013230 (2012).","journal-title":"Nature"},{"key":"99_CR36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nature11450","volume":"490","author":"J Qin","year":"2012","unstructured":"Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55\u201360 (2012).","journal-title":"Nature"},{"key":"99_CR37","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1001\/archgenpsychiatry.2010.168","volume":"67","author":"ZV Segal","year":"2010","unstructured":"Segal, Z. V. et al. Antidepressant monotherapy versus sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression. Arch. Gen. Psychiatry 67, 1256\u20131264 (2010).","journal-title":"Arch. Gen. Psychiatry"},{"key":"99_CR38","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","volume":"11","author":"M Vancamelbeke","year":"2017","unstructured":"Vancamelbeke, M. & Vermeire, S. The intestinal barrier: a fundamental role in health and disease. Expert Rev. Gastroenterol. Hepatol. 11, 821\u2013834 (2017).","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"99_CR39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","volume":"350","author":"I Spadoni","year":"2015","unstructured":"Spadoni, I. et al. A gut-vascular barrier controls the systemic dissemination of bacteria. Science 350, 830\u2013834 (2015).","journal-title":"Science"},{"key":"99_CR40","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1002\/hep.29760","volume":"67","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. & Hylemon, P. B. Gut-liver axis alterations in alcoholic liver disease: are bile acids the answer? Hepatology 67, 2074\u20132075 (2018).","journal-title":"Hepatology"},{"key":"99_CR41","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.jhep.2017.05.007","volume":"67","author":"R Wiest","year":"2017","unstructured":"Wiest, R., Albillos, A., Trauner, M., Bajaj, J. S. & Jalan, R. Targeting the gut-liver axis in liver disease. J. Hepatol. 67, 1084\u20131103 (2017).","journal-title":"J. Hepatol."},{"key":"99_CR42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096864","volume":"9","author":"S Bala","year":"2014","unstructured":"Bala, S., Marcos, M., Gattu, A., Catalano, D. & Szabo, G. Acute binge drinking increases serum endotoxin and bacterial DNA levels in healthy individuals. PLOS ONE 9, e96864 (2014).","journal-title":"PLOS ONE"},{"key":"99_CR43","doi-asserted-by":"crossref","first-page":"G131","DOI":"10.1152\/ajpgi.00103.2017","volume":"314","author":"RM Voigt","year":"2018","unstructured":"Voigt, R. M. et al. Diurnal variations in intestinal barrier integrity and liver pathology in mice: implications for alcohol binge. Am. J. Physiol. Gastrointest. Liver Physiol. 314, G131\u2013G141 (2018).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"99_CR44","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1080\/19490976.2015.1107696","volume":"6","author":"P Timary de","year":"2015","unstructured":"de Timary, P., Leclercq, S., Starkel, P. & Delzenne, N. A dysbiotic subpopulation of alcohol-dependent subjects. Gut Microbes 6, 388\u2013391 (2015).","journal-title":"Gut Microbes"},{"key":"99_CR45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053028","volume":"8","author":"L Bull-Otterson","year":"2013","unstructured":"Bull-Otterson, L. et al. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLOS ONE 8, e53028 (2013).","journal-title":"PLOS ONE"},{"key":"99_CR46","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1016\/j.ajpath.2011.08.039","volume":"179","author":"Y Wang","year":"2011","unstructured":"Wang, Y. et al. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. J. Pathol. 179, 2866\u20132875 (2011).","journal-title":"Am. J. Pathol."},{"key":"99_CR47","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.gastro.2014.09.014","volume":"148","author":"P Chen","year":"2015","unstructured":"Chen, P. et al. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology 148, 203\u2013214 (2015).","journal-title":"Gastroenterology"},{"key":"99_CR48","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.jhep.2018.05.021","volume":"69","author":"T Shao","year":"2018","unstructured":"Shao, T. et al. Intestinal HIF-1alpha deletion exacerbates alcoholic liver disease through inducing intestinal dysbiosis and barrier dysfunction. J. Hepatol. 69, 886\u2013895 (2018).","journal-title":"J. Hepatol."},{"key":"99_CR49","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.alcohol.2008.12.009","volume":"43","author":"CB Forsyth","year":"2009","unstructured":"Forsyth, C. B. et al. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43, 163\u2013172 (2009).","journal-title":"Alcohol"},{"key":"99_CR50","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/hep.24256","volume":"53","author":"B Nath","year":"2011","unstructured":"Nath, B. et al. Hepatocyte-specific hypoxia-inducible factor-1alpha is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53, 1526\u20131537 (2011).","journal-title":"Hepatology"},{"key":"99_CR51","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/acer.13498","volume":"41","author":"JS Bajaj","year":"2017","unstructured":"Bajaj, J. S. et al. Continued alcohol misuse in human cirrhosis is associated with an impaired gut-liver axis. Alcohol. Clin. Exp. Res. 41, 1857\u20131865 (2017).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"99_CR52","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.jhep.2013.12.019","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. et al. Altered profile of human gut microbiome is associated with cirrhosis and its complications. J. Hepatol. 60, 940\u2013947 (2014).","journal-title":"J. Hepatol."},{"key":"99_CR53","doi-asserted-by":"crossref","first-page":"G929","DOI":"10.1152\/ajpgi.00315.2013","volume":"306","author":"G Kakiyama","year":"2014","unstructured":"Kakiyama, G. et al. Colonic inflammation and secondary bile acids in alcoholic cirrhosis. Am. J. Physiol. Gastrointest. Liver Physiol. 306, G929\u2013G937 (2014).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"99_CR54","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2014.12.015","volume":"421","author":"L Wang","year":"2015","unstructured":"Wang, L. et al. Methods to determine intestinal permeability and bacterial translocation during liver disease. J. Immunol. Methods 421, 44\u201353 (2015).","journal-title":"J. Immunol. Methods"},{"key":"99_CR55","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1055\/s-2008-1040525","volume":"8","author":"BF Grant","year":"1988","unstructured":"Grant, B. F., Dufour, M. C. & Harford, T. C. Epidemiology of alcoholic liver disease. Semin. Liver Dis. 8, 12\u201325 (1988).","journal-title":"Semin. Liver Dis."},{"key":"99_CR56","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.alcohol.2014.07.021","volume":"49","author":"CB Forsyth","year":"2015","unstructured":"Forsyth, C. B., Voigt, R. M., Burgess, H. J., Swanson, G. R. & Keshavarzian, A. Circadian rhythms, alcohol and gut interactions. Alcohol 49, 389\u2013398 (2015).","journal-title":"Alcohol"},{"key":"99_CR57","volume":"10","author":"RD Couch","year":"2015","unstructured":"Couch, R. D. et al. Alcohol induced alterations to the human fecal VOC metabolome. PLOS ONE 10, e0119362 (2015).","journal-title":"PLOS ONE"},{"key":"99_CR58","doi-asserted-by":"crossref","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl Acad. Sci. USA 111, E4485\u2013E4493 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"99_CR59","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","volume":"360","author":"MR Lucey","year":"2009","unstructured":"Lucey, M. R., Mathurin, P. & Morgan, T. R. Alcoholic hepatitis. N. Engl. J. Med. 360, 2758\u20132769 (2009).","journal-title":"N. Engl. J. Med."},{"key":"99_CR60","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hep.29676","volume":"67","author":"P Hartmann","year":"2017","unstructured":"Hartmann, P. et al. Modulation of the intestinal bile acid-FXR-FGF15 axis improves alcoholic liver disease in mice. Hepatology 67, 2150\u20132166 (2017).","journal-title":"Hepatology"},{"key":"99_CR61","doi-asserted-by":"crossref","DOI":"10.1186\/s40168-017-0359-2","volume":"5","author":"VB Dubinkina","year":"2017","unstructured":"Dubinkina, V. B. et al. Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease. Microbiome 5, 141 (2017).","journal-title":"Microbiome"},{"key":"99_CR62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","volume":"513","author":"N Qin","year":"2014","unstructured":"Qin, N. et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513, 59\u201364 (2014).","journal-title":"Nature"},{"key":"99_CR63","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1002\/hep.27819","volume":"62","author":"JS Bajaj","year":"2015","unstructured":"Bajaj, J. S. et al. Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy. Hepatology 62, 1260\u20131271 (2015).","journal-title":"Hepatology"},{"key":"99_CR64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.5005\/jp-journals-10024-1296","volume":"14","author":"KV Raghava","year":"2013","unstructured":"Raghava, K. V., Shivananda, H., Mundinamane, D., Boloor, V. & Thomas, B. Evaluation of periodontal status in alcoholic liver cirrhosis patients: a comparative study. J. Contemp. Dent. Pract. 14, 179\u2013182 (2013).","journal-title":"J. Contemp. Dent. Pract."},{"key":"99_CR65","doi-asserted-by":"crossref","first-page":"G168","DOI":"10.1152\/ajpgi.00190.2011","volume":"302","author":"JS Bajaj","year":"2012","unstructured":"Bajaj, J. S. et al. Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G168\u2013G175 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"99_CR66","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1097\/MEG.0000000000000458","volume":"27","author":"SH Han","year":"2015","unstructured":"Han, S. H. et al. Effects of probiotics (cultured Lactobacillus subtilis\/Streptococcus faecium) in the treatment of alcoholic hepatitis: randomized-controlled multicenter study. Eur. J. Gastroenterol. Hepatol. 27, 1300\u20131306 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"99_CR67","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1053\/j.gastro.2014.08.031","volume":"147","author":"RK Dhiman","year":"2014","unstructured":"Dhiman, R. K. et al. Probiotic VSL#3 reduces liver disease severity and hospitalization in patients with cirrhosis: a randomized, controlled trial. Gastroenterology 147, 1327\u20131337 (2014).","journal-title":"Gastroenterology"},{"key":"99_CR68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-230X-14-40","volume":"14","author":"S Tuomisto","year":"2014","unstructured":"Tuomisto, S. et al. Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol. 14, 40 (2014).","journal-title":"BMC Gastroenterol."},{"key":"99_CR69","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/gutjnl-2015-310585","volume":"65","author":"M Llopis","year":"2016","unstructured":"Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65, 830\u2013839 (2016).","journal-title":"Gut"},{"key":"99_CR70","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/gutjnl-2016-313432","volume":"67","author":"C Grander","year":"2018","unstructured":"Grander, C. et al. Recovery of ethanol-induced Akkermansia muciniphila depletion ameliorates alcoholic liver disease. Gut 67, 891\u2013901 (2018).","journal-title":"Gut"},{"key":"99_CR71","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","volume":"69","author":"K Brandl","year":"2018","unstructured":"Brandl, K. et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J. Hepatol. 69, 396\u2013405 (2018).","journal-title":"J. Hepatol."},{"key":"99_CR72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.14949","volume":"48","author":"D Ciocan","year":"2018","unstructured":"Ciocan, D. et al. Bile acid homeostasis and intestinal dysbiosis in alcoholic hepatitis. Aliment. Pharmacol. Ther. 48, 961\u2013974 (2018).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"99_CR73","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1002\/hep.29623","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri, P. et al. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology 67, 1284\u20131302 (2018).","journal-title":"Hepatology"},{"key":"99_CR74","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4291\/wjgp.v5.i4.514","volume":"5","author":"W Zhong","year":"2014","unstructured":"Zhong, W. & Zhou, Z. Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J. Gastrointest. Pathophysiol. 5, 514\u2013522 (2014).","journal-title":"World J. Gastrointest. Pathophysiol."},{"key":"99_CR75","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s12199-015-0494-y","volume":"21","author":"S Harada","year":"2016","unstructured":"Harada, S. et al. Metabolomic profiling reveals novel biomarkers of alcohol intake and alcohol-induced liver injury in community-dwelling men. Environ. Health Prev. Med. 21, 18\u201326 (2016).","journal-title":"Environ. Health Prev. Med."},{"key":"99_CR76","doi-asserted-by":"crossref","first-page":"80381","DOI":"10.1039\/C5RA13417J","volume":"5","author":"Q Liang","year":"2015","unstructured":"Liang, Q., Wang, C., Li, B. & Zhang, A. Metabolomics of alcoholic liver disease: a clinical discovery study. RSC Adv. 5, 80381\u201380387 (2015).","journal-title":"RSC Adv."},{"key":"99_CR77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113860","volume":"9","author":"V Rachakonda","year":"2014","unstructured":"Rachakonda, V. et al. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways. PLOS ONE 9, e113860 (2014).","journal-title":"PLOS ONE"},{"key":"99_CR78","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ajg.2017.471","volume":"113","author":"JS Bajaj","year":"2018","unstructured":"Bajaj, J. S. et al. Prediction of fungal infection development and their impact on survival using the NACSELD cohort. Am. J. Gastroenterol. 113, 556\u2013563 (2018).","journal-title":"Am. J. Gastroenterol."},{"key":"99_CR79","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jhep.2013.09.011","volume":"60","author":"T Gustot","year":"2014","unstructured":"Gustot, T. et al. Invasive aspergillosis in patients with severe alcoholic hepatitis. J. Hepatol. 60, 267\u2013274 (2014).","journal-title":"J. Hepatol."},{"key":"99_CR80","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jhep.2016.04.029","volume":"65","author":"G Addolorato","year":"2016","unstructured":"Addolorato, G., Mirijello, A., Barrio, P. & Gual, A. Treatment of alcohol use disorders in patients with alcoholic liver disease. J. Hepatol. 65, 618\u2013630 (2016).","journal-title":"J. Hepatol."},{"key":"99_CR81","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/acer.13605","volume":"42","author":"BC Davis","year":"2018","unstructured":"Davis, B. C. & Bajaj, J. S. Effects of alcohol on the brain in cirrhosis: beyond hepatic encephalopathy. Alcohol. Clin. Exp. Res. 42, 660\u2013667 (2018).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"99_CR82","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11011-008-9129-y","volume":"24","author":"RF Butterworth","year":"2009","unstructured":"Butterworth, R. F. Thiamine deficiency-related brain dysfunction in chronic liver failure. Metab. Brain Dis. 24, 189\u2013196 (2009).","journal-title":"Metab. Brain Dis."},{"key":"99_CR83","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.3748\/wjg.v23.i30.5486","volume":"23","author":"MC Cenit","year":"2017","unstructured":"Cenit, M. C., Sanz, Y. & Codoner-Franch, P. Influence of gut microbiota on neuropsychiatric disorders. World J. Gastroenterol. 23, 5486\u20135498 (2017).","journal-title":"World J. Gastroenterol."},{"key":"99_CR84","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/alcalc\/agx024","volume":"52","author":"JE Temko","year":"2017","unstructured":"Temko, J. E. et al. The microbiota, the gut and the brain in eating and alcohol use disorders: a \u2018menage a trois\u2019? Alcohol Alcohol. 52, 403\u2013413 (2017).","journal-title":"Alcohol Alcohol."},{"key":"99_CR85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.toxlet.2018.01.021","volume":"287","author":"HW Xiao","year":"2018","unstructured":"Xiao, H. W. et al. Gut microbiota modulates alcohol withdrawal-induced anxiety in mice. Toxicol. Lett. 287, 23\u201330 (2018).","journal-title":"Toxicol. Lett."},{"key":"99_CR86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.15288\/jsad.2014.75.347","volume":"75","author":"GE Volpe","year":"2014","unstructured":"Volpe, G. E. et al. Associations of cocaine use and HIV infection with the intestinal microbiota, microbial translocation, and inflammation. J. Stud. Alcohol Drugs 75, 347\u2013357 (2014).","journal-title":"J. Stud. Alcohol Drugs"},{"key":"99_CR87","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11011-015-9746-1","volume":"31","author":"RF Butterworth","year":"2015","unstructured":"Butterworth, R. F. Pathogenesis of hepatic encephalopathy in cirrhosis: the concept of synergism revisited. Metab. Brain Dis. 31, 1211\u20131215 (2015).","journal-title":"Metab. Brain Dis."},{"key":"99_CR88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.28684","volume":"5","author":"JS Bajaj","year":"2014","unstructured":"Bajaj, J. S. The role of microbiota in hepatic encephalopathy. Gut Microbes 5, 397\u2013403 (2014).","journal-title":"Gut Microbes"},{"key":"99_CR89","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/hep.28696","volume":"64","author":"DJ Kang","year":"2016","unstructured":"Kang, D. J. et al. Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice. Hepatology 64, 1232\u20131248 (2016).","journal-title":"Hepatology"},{"key":"99_CR90","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1105703","volume":"365","author":"P Mathurin","year":"2011","unstructured":"Mathurin, P. et al. Early liver transplantation for severe alcoholic hepatitis. N. Engl. J. Med. 365, 1790\u20131800 (2011).","journal-title":"N. Engl. J. Med."},{"key":"99_CR91","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1053\/j.gastro.2018.04.009","volume":"155","author":"BP Lee","year":"2018","unstructured":"Lee, B. P. et al. Outcomes of early liver transplantation for patients with severe alcoholic hepatitis. Gastroenterology 155, 422\u2013430 (2018).","journal-title":"Gastroenterology"},{"key":"99_CR92","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.alcohol.2008.08.006","volume":"42","author":"IA Kirpich","year":"2008","unstructured":"Kirpich, I. A. et al. Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42, 675\u2013682 (2008).","journal-title":"Alcohol"},{"key":"99_CR93","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jhep.2008.02.015","volume":"48","author":"V Stadlbauer","year":"2008","unstructured":"Stadlbauer, V. et al. Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48, 945\u2013951 (2008).","journal-title":"J. Hepatol."},{"key":"99_CR94","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.cgh.2012.02.025","volume":"10","author":"GN Kalambokis","year":"2012","unstructured":"Kalambokis, G. N. et al. Rifaximin improves systemic hemodynamics and renal function in patients with alcohol-related cirrhosis and ascites. Clin. Gastroenterol. Hepatol. 10, 815\u2013818 (2012).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"99_CR95","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/jgh.12070","volume":"28","author":"J Vlachogiannakos","year":"2013","unstructured":"Vlachogiannakos, J. et al. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J. Gastroenterol. Hepatol. 28, 450\u2013455 (2013).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"99_CR96","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1053\/j.gastro.2015.05.008","volume":"149","author":"CR Kelly","year":"2015","unstructured":"Kelly, C. R. et al. Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook. Gastroenterology 149, 223\u2013237 (2015).","journal-title":"Gastroenterology"},{"key":"99_CR97","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/hep.28121","volume":"63","author":"D Kao","year":"2016","unstructured":"Kao, D. et al. Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology 63, 339\u2013340 (2016).","journal-title":"Hepatology"},{"key":"99_CR98","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/hep.29306","volume":"66","author":"JS Bajaj","year":"2017","unstructured":"Bajaj, J. S. et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology 66, 1727\u20131738 (2017).","journal-title":"Hepatology"},{"key":"99_CR99","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","volume":"143","author":"A Vrieze","year":"2012","unstructured":"Vrieze, A. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143, 913\u2013916 (2012).","journal-title":"Gastroenterology"},{"key":"99_CR100","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.cgh.2016.10.029","volume":"15","author":"CA Philips","year":"2017","unstructured":"Philips, C. A. et al. Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study. Clin. Gastroenterol. Hepatol. 15, 600\u2013602 (2017).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"99_CR101","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12664-018-0859-4","volume":"37","author":"CA Philips","year":"2018","unstructured":"Philips, C. A., Phadke, N., Ganesan, K., Ranade, S. & Augustine, P. Corticosteroids, nutrition, pentoxifylline, or fecal microbiota transplantation for severe alcoholic hepatitis. Indian J. Gastroenterol. 37, 215\u2013225 (2018).","journal-title":"Indian J. Gastroenterol."},{"key":"99_CR102","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/hep4.1020","volume":"1","author":"DJ Kang","year":"2017","unstructured":"Kang, D. J. et al. Gut microbial composition can differentially regulate bile acid synthesis in humanized mice. Hepatol. Commun. 1, 61\u201370 (2017).","journal-title":"Hepatol. Commun."},{"key":"99_CR103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.chom.2016.01.003","volume":"19","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation. Cell Host Microbe 19, 227\u2013239 (2016).","journal-title":"Cell Host Microbe"},{"key":"99_CR104","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen, Y. et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562\u2013572 (2011).","journal-title":"Hepatology"},{"key":"99_CR105","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jhep.2013.01.003","volume":"58","author":"G Kakiyama","year":"2013","unstructured":"Kakiyama, G. et al. Modulation of the fecal bile acid profile by gut microbiota in cirrhosis. J. Hepatol. 58, 949\u2013955 (2013).","journal-title":"J. Hepatol."}],"container-title":["Nature Reviews Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0099-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41575-018-0099-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:51:04Z","timestamp":1684605064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41575-018-0099-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":105,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1038\/s41575-018-0099-1","relation":{},"ISSN":["1759-5045","1759-5053"],"issn-type":[{"value":"1759-5045","type":"print"},{"value":"1759-5053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,14]]},"assertion":[{"value":"14 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.S.B. declares no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}